The relationship between evolution and engineering has always been one of careful observation followed by imitation. Since Darwin articulated the logic of natural selection in the nineteenth century, biologists have understood that biological complexity is not designed but selected — the accumulated product of variation and differential survival across geological time. Directed evolution, the laboratory distillation of this principle, has for decades allowed researchers to accelerate the process artificially, shaping enzymes, antibodies, and other proteins toward desired functions with remarkable efficiency. A study published on 9 March 2026 in Cell by Gligorovski, Labagnara, and colleagues at EPFL’s Laboratory of the Physics of Biological Systems now extends this paradigm in a fundamentally new direction, introducing a technique — optovolution — that may transform the way dynamically behaving proteins are engineered.
The limitation of conventional directed evolution lies in its intrinsic logic: selection pressure is typically constant, favouring proteins that remain constitutively active. Yet the protein landscape of living cells is anything but static. Molecular switches, signalling cascades, and transcriptional logic gates all depend on proteins that alternate between active and inactive states in a precisely timed, context-dependent manner. A protein that cannot be switched off may be as pathological as one that cannot be switched on; continuous selection for activity alone inevitably degrades the switching capacity that defines functional biological behaviour.
Optovolution addresses this by coupling directed evolution to optogenetics within a single integrated living system. The researchers engineered Saccharomyces cerevisiae so that cell cycle progression — and thus survival — depended on a target protein performing correctly timed state transitions. Pulses of light, delivered with temporal precision, forced the protein to alternate between active and inactive conformations; variants that switched at the wrong moment caused the yeast cell to stall or die, while well-performing variants reproduced and propagated. With each cell cycle lasting approximately 90 minutes, the system functioned as a rapid, iterative molecular fitness test.
The results were strikingly productive. The team evolved 19 new variants of a widely used light-controlled transcription factor, several of which exhibited enhanced sensitivity, reduced dark-state leakage, or — notably — the capacity to respond to green rather than blue light, a spectral shift long considered technically intractable. Beyond light-sensing proteins, optovolution was further demonstrated to evolve a transcription factor capable of Boolean AND-gate logic, activating its target gene only when two independent inputs — one optical, one chemical — coincided.
The therapeutic implications deserve careful consideration. The ability to engineer proteins with programmable, multi-state dynamics may open new avenues in synthetic biology and precision medicine, where cellular circuits capable of sensing, computing, and responding to complex intracellular states could underpin next-generation gene therapies, biosensors, and cell-based therapeutics. Optovolution may ultimately prove to be not merely a technical refinement of directed evolution, but a conceptual expansion — one in which the temporal dimension of protein function is, for the first time, a direct target of selection.
Leave a Reply